These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25693085)

  • 41. Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Akitake M; Yamaguchi A; Shiota M; Imada K; Tatsugami K; Yokomizo A; Naito S; Eto M
    Anticancer Res; 2019 Aug; 39(8):4325-4328. PubMed ID: 31366524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy.
    Bayraktar Z; Gurbuz G; Taşci AI; Sevin G
    Int Urol Nephrol; 2001; 33(4):627-9. PubMed ID: 12452614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.
    Hwang MJ; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Am J Clin Pathol; 2020 Jul; 154(2):208-214. PubMed ID: 32253420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].
    Brun A; Koutlidis N; Thibault T; Escoffier A; Bardet F; Cormier L
    Prog Urol; 2023 Mar; 33(3):125-134. PubMed ID: 36604247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    Li Z; Li Y; Lu Q; Chen J
    ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controversies in the management of T1 urothelial bladder cancer.
    Azzouz H; Cauberg EC; De Reijke TM
    Minerva Urol Nefrol; 2011 Dec; 63(4):309-15. PubMed ID: 21996986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer?
    Badalato G; Patel T; Hruby G; McKiernan J
    BJU Int; 2011 Oct; 108(8):1292-6. PubMed ID: 21176080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
    Hrbáček J; Macek P; Ali-El-Dein B; Thalmann GN; Stenzl A; Babjuk M; Shaaban AA; Gakis G
    Urol Int; 2015; 94(1):45-9. PubMed ID: 25171129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.
    Cheng L; Weaver AL; Neumann RM; Scherer BG; Bostwick DG
    Cancer; 1999 Sep; 86(6):1035-43. PubMed ID: 10491531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmacytoid urothelial carcinoma of the bladder.
    Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
    Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
    Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
    Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.
    Aziz A; Gierth M; Rink M; Schmid M; Chun FK; Dahlem R; Roghmann F; Palisaar RJ; Noldus J; Ellinger J; Müller SC; Pycha A; Martini T; Bolenz C; Moritz R; Herrmann E; Keck B; Wullich B; Mayr R; Fritsche HM; Burger M; Bastian PJ; Seitz C; Brookman-May S; Xylinas E; Shariat SF; Fisch M; May M;
    World J Urol; 2015 Dec; 33(12):1945-50. PubMed ID: 25947885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
    Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.